You are here

New Duke research could make HIV incidence tracking faster, cheaper

Tuesday, January 23, 2018

Researchers at the Duke Human Vaccine Institute have recently developed a tool that more accurately discerns new HIV infections from long-standing ones.

Their strategy involved searching patient samples for antibodies, the proportions or components of which might differ based on whether patients are facing recent or long-standing infections. The newer method is more accurate in its intended measurements compared to existing tools and also requires less samples for population-level inferences, explained Georgia Tomaras, director of research at DHVI and senior author of the study. She added that these advances, collectively, could save governments and NGOs tracking HIV incidence time and money.

 

Please click here for the full article.